|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Natural history/Epidemiology, Supportive care
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
CR002455 NCT00264108
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
66 to 80
|
|
|
|
Other
|
|
|
|
LNH03-6B NCT00144755
|
|
|
|
|
|
|
|
Last Modified: 3/6/2008  First Published: 1/20/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
Geriatric
|
|
|
|
Other, Pharmaceutical / Industry
|
|
|
|
GCLLSG-CLL9 EU-20561, AMGEN-GCLLSG-CLL9, EUDRACT-2005-003014-15, NCT00281892
|
|
|
|
|
|
|
|
Last Modified: 8/25/2008  First Published: 4/17/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MAYO-MC04CC MC04CC, NCT00661999
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care, Treatment
|
|
|
|
Active
|
|
|
|
18 to 65
|
|
|
|
Other
|
|
|
|
jth_004 NCT00204633
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
GFM-DAR500-2006-01 NCT00443339
|
|
|
|
|
|
|
|
Last Modified: 3/30/2006  First Published: 3/24/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Treatment
|
|
|
|
Active
|
|
|
|
18 to 65
|
|
|
|
Other, Pharmaceutical / Industry
|
|
|
|
WGSG-ARA-PLUS AVENTIS-WGSG-ARA-PLUS, SANOFI-WGSF-ARA-PLUS, EU-205108, NCT00309920
|
|
|
|
|
|
|
|
Last Modified: 4/3/2008  First Published: 12/21/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Supportive care
|
|
|
|
Active
|
|
|
|
18 and over
|
|
|
|
NCI, Pharmaceutical / Industry
|
|
|
|
MCCRC-RC05CB MCCRC-06-002991, ORTHO-MCCRC-RC05CB, NCT00416624
|
|
|
|